Abstract
The absorption of insulin across the vaginal mucosa into the systemic circulation was studied in ovariectomized rats given subsequent estrogen treatment. Blood glucose levels were determined as an indirect measure of insulin absorption, and the effect of various enhancers on the hypoglycemic response was investigated. In the absence of any enhancer, no decrease in blood glucose levels was observed after vaginal administration of insulin. However, the coadministration of sodium taurodihydrofusidate, polyoxyethylene-9-lauryl ether, lysophosphatidylcholine, palmitoylcarnitine chloride, and lysophosphatidylglycerol significantly increased hypoglycemia, whereas citric acid had little effect. The histological changes in the vaginal epithelium after treatment with the enhancer systems were variable and often severe. While the efficacy of these compounds in promoting the vaginal absorption of insulin is encouraging, their mechanisms of action and long-term histological effects are yet to be defined.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
J. L. Richardson and L. Illum. The vaginal route of peptide and protein drug delivery. Adv. Drug Del. Rev. 8:341–366 (1992).
V. H. L. Lee. Enzymatic barriers to peptide and protein absorption and the use of penetration enhancers to modify absorption. In S. S. Davis, L. Illum, and E. Tomlinson (eds.), Delivery Systems for Peptide Drugs, Plenum Medical, New York, 1986, pp. 87–104.
J. L. Richardson, P. S. Minhas, N. W. Thomas, and L. Illum. Vaginal administration of gentamicin to rats. Pharmaceutical and morphological studies using absorption enhancers. Int. J. Pharm. 56:29–35 (1989).
H. Okada, I. Yamazaki, Y. Ogawa, S. Hirai, T. Yashiki, and H. Mima. Vaginal administration of a potent luteinizing hormone-releasing hormone analog (leuprolide) in rats. Absorption by different routes and absorption enhancement. J. Pharm. Sci. 71:1367–1371 (1982).
W. A. Lee, R. E. Ennis, and L. C. Foster. Histological studies of insulin absorption across the nasal mucosa in the presence of sodium taurodihydrofusidate (STDHF). Proc. Int. Symp. Control. Rel. Bioact. Mater. 15:70–71 (1988).
J. D. Elashoff. Down with multiple T-tests. Gastroenterology 80:615–620 (1981).
D. T. O'Hagan and L. Illum. Absorption of peptides and proteins from the respiratory tract and the potential for development of locally administered vaccines. Ther. Drug Carrier Syst. 7:35–97 (1990).
S. Hirai, T. Yashiki, and H. Mima. Mechanisms for the enhancement of the nasal absorption of insulin by surfactants. Int. J. Pharm. 9:137–281 (1981).
A. L. Daugherty, H. D. Liggett, J. G. McCabe, J. A. Moore, and J. S. Patton. Absorption of recombinant methionyl-human growth hormone (Met-hGH) from rat nasal mucosa. Int. J. Pharm. 45:197–206 (1988).
H. Okada. Vaginal route of peptide and protein drug delivery. In V. H. L. Lee (ed.), Peptide and Protein Drug Delivery, Marcel Dekker, New York, 1991, pp. 633–666.
J. P. Longenecker. Transnasal systemic delivery of insulin. In S. S. Davis, L. Illum, and E. Tomlinson (eds.), Delivery Systems for Peptide Drugs, Plenum Medical, New York, 1986, pp. 221–220.
J. P. Longenecker, A. C. Moses, J. S. Flier, R. D. Silver, M. C. Carey, and E. J. Dubovi. Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep. J. Pharm. Sci. 76:351–355 (1987).
D. A. Eppstein and J. P. Longenecker. Alternative delivery systems for peptides and proteins as drugs. CRC Crit. Rev. Ther. Drug Carrier Syst. 5:99–139 (1988).
G. S. Gordon, A. C. Moses, R. D. Silver, J. S. Flier, and M. D. Carey. Nasal absorption of insulin: Enhancement by hydrophobic bile salts. Proc. Natl. Acad. Sci. USA 82:7419–7423 (1985).
R. D. Ennis, L. Borden, and W. A. Lee. The effects of permeation enhancers on the surface morphology of the rat nasal mucosa: A scanning electron microscopy study. Pharm. Res. 7:468–475 (1991).
E. J. Van Hoogdalem, C. Vermeij-Kerrs, A. G. de Boer, and D. D. Breimer. Topical effects of absorption enhancing agents on the rectal mucosa of rats in vivo. J. Pharm. Sci. 79:866–870 (1990).
J. A. Fix, K. Engle, P. A. Porter, P. S. Leppert, S. J. Selk, C. R. Gardner, and J. Alexander. Acylcarnitines: Drug absorption enhancing agents in the gastrointestinal tract. Am. J. Physiol. 14:G332–G340 (1986).
E. L. Lecluyse, L. E. Appel, and S. C. Sutton. Relationship between drug absorption enhancing activity and membrane perturbing effects of acylcarnitines. Pharm. Res. 8:84–87 (1991).
L. Illum, N. F. Farraj, H. Critchley, B. R. Johansen, and S. S. Davis. Nasal administration of gentamicin using a novel microsphere delivery system. Int. J. Pharm. 57:49–54 (1989).
H. Okada, I. Yamazaki, T. Yashiki, and H. Mima. Vaginal absorption of a potent luteinizing hormone-releasing hormone analogue (leuprolide) in rats. II. Mechanism of absorption enhancement with organic acids. J. Pharm. Sci. 72:75–78 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Richardson, J.L., Illum, L. & Thomas, N.W. Vaginal Absorption of Insulin in the Rat: Effect of Penetration Enhancers on Insulin Uptake and Mucosal Histology. Pharm Res 9, 878–883 (1992). https://doi.org/10.1023/A:1015892630637
Issue Date:
DOI: https://doi.org/10.1023/A:1015892630637